Provided by Tiger Trade Technology Pte. Ltd.

Seres Therapeutics

4.77
+0.04000.84%
Volume:4K
Turnover:21.14K
Market Cap:47.91M
PE:-1.98
High:4.77
Open:4.77
Low:4.77
Close:4.76
52wk High:29.98
52wk Low:4.32
Shares:10.04M
Float Shares:8.83M
Volume Ratio:0.59
T/O Rate:0.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.4137
EPS(LYR):0.6400
ROE:-66.57%
ROA:-39.85%
PB:1.39
PE(LYR):7.45

Loading ...

Jun 22, 2020

Major Issues Report

8-K - Current report
May 07, 2020

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 07, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Mar 23, 2020

Major Issues Report

Current report, item 5.02
Mar 18, 2020

Major Issues Report

Current report, items 1.01, 8.01, and 9.01
Mar 16, 2020

Correspondence

CORRESP [Cover] - Correspondence
Mar 02, 2020

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Mar 02, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 02, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 12, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 12, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 07, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 07, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Dec 16, 2019

Major Issues Report

Current report, item 5.02
Nov 27, 2019

Major Issues Report

Current report, items 1.01 and 9.01
Nov 12, 2019

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Nov 05, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Nov 05, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Nov 04, 2019

Major Issues Report

Current report, items 1.01, 2.03, and 9.01